| Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients. | |
| | |
MedLine Citation:
|
PMID: 18980797 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
INTRODUCTION: Thrombolytic therapy improves clinical outcome in patients with acute ischemic stroke but is compromised by symptomatic intracranial hemorrhage and an unpredictable therapeutic response. In vitro and in vivo data suggest that activation of procarboxypeptidase U (proCPU) inhibits fibrinolysis. AIMS: To investigate whether the extent of proCPU activation is related to efficacy and safety of thrombolytic therapy in ischemic stroke patients. METHODS: In twelve patients with ischemic stroke who were treated with intravenous (n=7) or intra-arterial (n=5) thrombolysis, venous blood samples were taken at different time points before, during and after thrombolytic therapy. ProCPU and carboxypeptidase U (CPU, TAFIa) plasma concentrations were determined by HPLC. The maximal CPU activity (CPU(max)) and the percentage of proCPU consumption during thrombolytic therapy were calculated. The efficacy and safety of the thrombolytic therapy were assessed by evolution of the clinical deficit, recanalisation, final infarct volume, thrombolysis-induced intracranial hemorrhage and mortality. RESULTS: No correlations between CPU(max) or proCPU consumption and patient or stroke characteristics were found. However, CPU(max) is associated with evolution of the clinical deficit and achieved recanalisation. ProCPU consumption is related to the risk of intracranial hemorrhage, mortality and final infarct volume. CONCLUSIONS: Irrespective of patient and stroke characteristics, CPU(max) and proCPU consumption during thrombolytic treatment for ischemic stroke are parameters for therapeutic efficacy and safety. Further evaluation of the clinical applicability of these parameters and further investigation of the potential role for CPU inhibitors as adjunctive therapeutics during thrombolytic treatment may be of value. |
| | |
Authors:
|
Raf Brouns; Evelien Heylen; Rishi Sheorajpanday; Johan L Willemse; Jan Kunnen; Didier De Surgeloose; Dirk F Hendriks; Peter P De Deyn |
Related Documents
:
|
7758177 - More rapid, complete, and stable coronary thrombolysis with bolus administration of ret... 2203557 - Revascularization for acute myocardial infarction. strategies in need of revision. 2407157 - Improved left ventricular function in myocardial infarction following intravenous throm... 2248217 - Role of echocardiography in acute myocardial infarction. 22292457 - Type of desmin expression in cardiomyocytes -a good marker of heart failure development... 15212127 - First clinical use of the redesigned heartmate ii left ventricular assist system in the... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-11-02 |
Journal Detail:
|
Title: Clinical neurology and neurosurgery Volume: 111 ISSN: 1872-6968 ISO Abbreviation: Clin Neurol Neurosurg Publication Date: 2009 Feb |
Date Detail:
|
Created Date: 2009-01-26 Completed Date: 2009-03-09 Revised Date: 2009-10-14 |
Medline Journal Info:
|
Nlm Unique ID: 7502039 Medline TA: Clin Neurol Neurosurg Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 165-70 Citation Subset: IM |
Affiliation:
|
Department of Neurology and Memory Clinic, ZNA Middelheim Hospital, Antwerp, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Brain Ischemia / drug therapy*, physiopathology Carboxypeptidase U / blood* Chromatography, High Pressure Liquid / methods Enzyme Precursors / blood Female Humans Infarction / diagnosis, etiology Intracranial Hemorrhages / diagnosis, etiology Intracranial Thrombosis / complications, drug therapy Male Middle Aged Stroke / drug therapy*, physiopathology Survival Rate Thrombolytic Therapy / adverse effects, methods*, mortality Time Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Enzyme Precursors; EC 3.4.17.20/Carboxypeptidase U |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Actively bleeding intracranial aneurysm demonstrated by CT angiography.
Next Document: Holocord pilocytic astrocytoma--case report and review of the literature.